Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature
- PMID: 29581706
- PMCID: PMC5861608
- DOI: 10.1186/s12901-018-0052-5
Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature
Abstract
Background: Sarcomas comprise a diverse group of soft tissue mesenchymal malignancies. The sinuses and nasal region are a relatively rare site of sarcomas.
Methods: Retrospective review of the literature on sinonasal sarcomas from 1987-2017. Data were analyzed for demographics, treatment type, stage, and histopathologic type. Kaplan-Meier analysis was used to assess and compare survival.
Results: A total of 198 cases of sinonasal sarcoma were identified and analyzed. The median age at diagnosis was 39 years. Overall 5-, 10-, and 20-year survival was 61.3%, 58.9%, and 49.1%, respectively, and disease-free 5-, 10-, and 20-year survival was 53.2%, 49.1%, and 38.3%, respectively. Lymph node metastasis was present at diagnosis in 3.0% of cases, and distant metastasis was present in 3.5% of cases. On univariate analysis T stage, overall stage, treatment type, histopathologic subtype, and presence of distant metastasis significantly affected survival. On multivariate analysis overall stage alone significantly predicted overall survival. Open vs. endoscopic surgery, total radiation dose, and presence of neck metastasis did not significantly affect survival. Combined modality treatment was associated with higher survival rates than single modality therapy.
Conclusions: Sinonasal sarcoma is a relatively rare malignancy. Lower T and overall stage, lack of distant metastasis, and multimodality therapy were associated with improved survival. Certain histopathologic subtypes were associated with poorer survival.
Keywords: Endoscopic; Kaplan-Meier; Sinonasal cancer; Sinonasal sarcoma; Survival.
Conflict of interest statement
Not applicable.Not applicable.The author declares that he has no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database.BMC Ear Nose Throat Disord. 2018 Aug 9;18:13. doi: 10.1186/s12901-018-0061-4. eCollection 2018. BMC Ear Nose Throat Disord. 2018. PMID: 30116158 Free PMC article.
-
Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.Clin Orthop Relat Res. 2018 Mar;476(3):589-598. doi: 10.1007/s11999.0000000000000057. Clin Orthop Relat Res. 2018. PMID: 29529647 Free PMC article.
-
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.Laryngoscope. 2021 May;131(5):E1468-E1475. doi: 10.1002/lary.29102. Epub 2020 Sep 18. Laryngoscope. 2021. PMID: 32946597
-
Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.Oral Maxillofac Surg. 2009 Dec;13(4):191-9. doi: 10.1007/s10006-009-0170-8. Oral Maxillofac Surg. 2009. PMID: 19795137 Review.
-
Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors.Int J Radiat Oncol Biol Phys. 1995 Oct 15;33(3):585-93. doi: 10.1016/0360-3016(95)00256-X. Int J Radiat Oncol Biol Phys. 1995. PMID: 7558947 Review.
Cited by
-
Clinical course and vascular endothelial growth factor signaling system expression in maxillary angiosarcoma: A case report.Sci Prog. 2024 Jul-Sep;107(3):368504241274022. doi: 10.1177/00368504241274022. Sci Prog. 2024. PMID: 39196593 Free PMC article.
-
Angiosarcoma of the Maxillary Sinus: A Case Report.Cureus. 2024 Jun 25;16(6):e63131. doi: 10.7759/cureus.63131. eCollection 2024 Jun. Cureus. 2024. PMID: 39055444 Free PMC article.
-
Highly Aggressive Osteosarcoma of the Ethmoids and Maxillary Sinus-A Case of Successful Surgery and Proton Beam Radiotherapy in a 65-Year-Old Man.Medicina (Kaunas). 2022 Aug 23;58(9):1141. doi: 10.3390/medicina58091141. Medicina (Kaunas). 2022. PMID: 36143818 Free PMC article.
-
Endoscopic endonasal resection of sinonasal teratocarcinosarcoma with intracranial breakthrough: illustrative case.J Neurosurg Case Lessons. 2021 Oct 18;2(16):CASE21471. doi: 10.3171/CASE21471. eCollection 2021 Oct 18. J Neurosurg Case Lessons. 2021. PMID: 35855277 Free PMC article.
-
Multimodal Treatment With Orbital Organ Preservation in Adult Patients With Locally Advanced Small-Round-Cell Malignancy of the Nasal Cavity and Paranasal Sinus.Front Oncol. 2021 Apr 1;11:650385. doi: 10.3389/fonc.2021.650385. eCollection 2021. Front Oncol. 2021. PMID: 33869053 Free PMC article.
References
-
- Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi M, et al. Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years. Clin Oral Investig. 2004;8(2):52–55. - PubMed
-
- Stavrakas M, Nixon I, Andi K, Oakley R, Jeannon JP, Lyons A, et al. Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol. 2016;130(9):850–859. - PubMed
-
- Stepan K, Konuthula N, Khan M, Parasher A, Del Signore A, Govindaraj S, et al. Outcomes in Adult Sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg. 2017;157(1):135–141. - PubMed
-
- Unsal AA, Chung SY, Unsal AB, Baredes S, Eloy JA. A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg. 2017;157(1):142–149. - PubMed
-
- Gerth DJ, Tashiro J, Thaller SR. Pediatric sinonasal tumors in the United States: incidence and outcomes. J Surg Res. 2014;190(1):214–220. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources